Lilly to acquire Versanis for up to $1.93 billion
Eli Lilly and Co said on Friday it will acquire privately held drug developer Versanis for up to $1.93 billion, adding to its portfolio of obesity drugs.
Source: www.reuters.com
1 Min Read
(Reuters) - Eli Lilly and Co said on Friday it will acquire privately held drug developer Versanis for up to $1.93 billion, adding to its portfolio of obesity drugs.
Reporting by Sriparna Roy in Bengaluru; Editing by Arun Koyyur
